Results 71 to 80 of about 489,406 (280)
Discrimination of bladder cancer cells from normal urothelial cells with high specificity and sensitivity:combined application of atomic force microscopy and modulated Raman spectroscopy [PDF]
, 2014 Atomic force microscopy (AFM) and modulated Raman spectroscopy (MRS) were used to discriminate between living normal human urothelial cells (SV-HUC-1) and bladder tumour cells (MGH-U1) with high specificity and sensitivity.
Adya, Ashok K. +5 more
core +2 more sources
Frontiers in OncologyIntroductionEnfortumab vedotin (EV) is an antibody drug conjugate approved for advanced urothelial cancer, consisting of a monomethyl auristatin E payload linked to a human monoclonal antibody targeting nectin-4.
Evangelia Vlachou +16 more
doaj +1 more source
Diagnostics, 2021 In bladder cancer, urothelial carcinoma is the most common histologic subtype, accounting for more than 90% of cases. Pathogenic effects due to the dysbiosis of gut microbiota are localized not only in the colon, but also in regulating bladder cancer ...
Yen-Chieh Wang +6 more
doaj +1 more source
Investigation Toward The Economic Feasibility of Personalized Medicine For Healthcare Service Providers: The Case of Bladder Cancer [PDF]
arXiv, 2023 In today's complex healthcare landscape, the pursuit of delivering optimal patient care while navigating intricate economic dynamics poses a significant challenge for healthcare service providers (HSPs). In this already complex dynamics, the emergence of clinically promising personalized medicine based treatment aims to revolutionize medicine.
arxiv
BMJ, 2014 A 76 year old woman reports recurrent urinary frequency, dysuria, and malodorous urine. No bacterial growth has been identified on two midstream urine samples, though empirical treatment with antibiotics has improved her symptoms. After three months, an episode of visible haematuria prompts referral and a transitional cell carcinoma of the bladder is ...
Nicholson, B, McGrath, J, Hamilton, W
openaire +4 more sources
Cells, 2022 Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear.
Guanghou Fu +9 more
doaj +1 more source
Forecasting per-patient dosimetric benefit from daily online adaptive radiotherapy for cervical cancer [PDF]
arXiv, 2022 Adaptive Radiotherapy (ART) is an emerging technique for treating cancer patients which facilitates higher delivery accuracy and has the potential to reduce toxicity. However, ART is also resource-intensive, requiring extra human and machine time compared to standard treatment methods.
arxiv
Fully Automated Organ Segmentation in Male Pelvic CT Images [PDF]
Balagopal A, Kazemifar S, Nguyen D, Lin M H, Hannan R, Owrangi A
and Jiang S 2018 Fully automated organ segmentation in male pelvic CT images
Phys. Med. Biol. 63 245015, 2018 Accurate segmentation of prostate and surrounding organs at risk is important for prostate cancer radiotherapy treatment planning. We present a fully automated workflow for male pelvic CT image segmentation using deep learning. The architecture consists of a 2D localization network followed by a 3D segmentation network for volumetric segmentation of ...
arxiv +1 more source
Pathobiology and Chemoprevention of Bladder Cancer [PDF]
, 2011 Our understanding of the pathogenesis of bladder cancer has improved considerably over the past decade. Translating these novel pathobiological discoveries into therapies, prevention, or strategies to manage patients who are suspected to have or who have
Katsuhito Miyazawa +4 more
core +2 more sources
ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
Cell Death and Disease, 2021 Bladder cancer is one of the most common malignant tumors in the urinary system. The development and improvement of treatment efficiency require the deepening of the understanding of its molecular mechanism.
Yuchen Wang +10 more
doaj +1 more source